Чланци са овлашћеним јавним приступом - Runping Liu, Ph.DСазнајте више
Није доступно нигде: 16
Natural products in licorice for the therapy of liver diseases: Progress and future opportunities
X Li, R Sun, R Liu
Pharmacological Research 144, 210-226, 2019
Овлашћења: National Natural Science Foundation of China
Continued Alcohol Misuse in Human Cirrhosis is Associated with An Impaired Gut‐Liver Axis
JS Bajaj, G Kakiyama, D Zhao, H Takei, A Fagan, P Hylemon, H Zhou, ...
Alcoholism: Clinical and Experimental Research, 2017
Овлашћења: US Department of Veterans Affairs
Toxicity of traditional Chinese medicine herbal and mineral products
R Liu, X Li, N Huang, M Fan, R Sun
Advances in Pharmacology 87, 301-346, 2020
Овлашћења: National Natural Science Foundation of China
Evodiamine and rutaecarpine from Tetradium ruticarpum in the treatment of liver diseases
X Li, J Ge, Q Zheng, J Zhang, R Sun, R Liu
Phytomedicine 68, 153180, 2020
Овлашћења: National Natural Science Foundation of China
UDCA and CDCA alleviate 17α-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats
X Li, Z Yuan, R Liu, HM Hassan, H Yang, R Sun, L Zhang, Z Jiang
Toxicology and Applied Pharmacology 311, 12-25, 2016
Овлашћења: National Natural Science Foundation of China
Human antigen R: A potential therapeutic target for liver diseases
R Liu, K Wu, Y Li, R Sun, X Li
Pharmacological Research 155, 104684, 2020
Овлашћења: National Natural Science Foundation of China
Alpha-naphthylisothiocyanate impairs bile acid homeostasis through AMPK-FXR pathways in rat primary hepatocytes
X Li, R Liu, L Yu, Z Yuan, R Sun, H Yang, L Zhang, Z Jiang
Toxicology 370, 106-115, 2016
Овлашћења: National Natural Science Foundation of China
Saikosaponin D attenuates metabolic associated fatty liver disease by coordinately tuning PPARα and INSIG/SREBP1c pathway
Y Gu, S Duan, M Ding, Q Zheng, G Fan, X Li, Y Li, C Liu, R Sun, R Liu
Phytomedicine 103, 154219, 2022
Овлашћења: National Natural Science Foundation of China
Si-Ni-San ameliorates chronic colitis by modulating type I interferons-mediated inflammation
Y Cai, B Xu, F Zhou, J Wu, S Li, Q Zheng, Y Li, X Li, F Gao, S Dong, R Liu
Phytomedicine 84, 153495, 2021
Овлашћења: National Natural Science Foundation of China
Tannins in Terminalia bellirica inhibit hepatocellular carcinoma growth by regulating EGFR-signaling and tumor immunity
Z Chang, P Jian, Q Zhang, W Liang, K Zhou, Q Hu, Y Liu, R Liu, L Zhang
Food & Function 12 (8), 3720-3739, 2021
Овлашћења: National Natural Science Foundation of China
The emerging role of AMP-activated protein kinase in cholestatic liver diseases
X Li, R Liu, L Zhang, Z Jiang
Pharmacological research 125, 105-113, 2017
Овлашћења: National Natural Science Foundation of China
Saikosaponins ameliorate hyperlipidemia in rats by enhancing hepatic lipid and cholesterol metabolism
Q Zheng, X Li, N Huang, F Li, J Ge, D Wang, R Sun, R Liu
Journal of ethnopharmacology 305, 116110, 2023
Овлашћења: National Natural Science Foundation of China
Si–Ni-San improves experimental colitis by favoring Akkermensia colonization
Y Cai, X Li, Q Han, J Bai, Q Zheng, R Sun, R Liu
Journal of Ethnopharmacology 305, 116067, 2023
Овлашћења: National Natural Science Foundation of China
A novel tri‐functional liposome Re‐educates “Cold Tumor” and abrogates tumor growth by synergizing autophagy inhibition and PD‐L1 blockade
F Zhou, X Li, X Xue, S Li, G Fan, Y Cai, Z Chang, J Qu, R Liu
Advanced healthcare materials 12 (11), 2202757, 2023
Овлашћења: National Natural Science Foundation of China
Total glucosides of paeony alleviates scleroderma by inhibiting type I interferon responses
S Li, J Bai, G Fan, R Liu
Journal of Ethnopharmacology 302, 115897, 2023
Овлашћења: National Natural Science Foundation of China
Tannins in Phyllanthus emblica L. improves cisplatin efficacy in lung cancer cells by boosting endoplasmic reticulum stress to trigger immunogenic cell death
Q Hu, S Wang, R Cheng, Y Liu, Z Chang, Y Huang, Y Chen, X Luo, ...
Phytomedicine 123, 155219, 2024
Овлашћења: National Natural Science Foundation of China
Доступно негде: 51
Cholangiocyte‐derived exosomal long noncoding RNA H19 promotes hepatic stellate cell activation and cholestatic liver fibrosis
R Liu, X Li, W Zhu, Y Wang, D Zhao, X Wang, EC Gurley, G Liang, ...
Hepatology 70 (4), 1317-1335, 2019
Овлашћења: US National Institutes of Health, US Department of Veterans Affairs
The role of sphingosine 1‐phosphate receptor 2 in bile‐acid–induced cholangiocyte proliferation and cholestasis‐induced liver injury in mice
Y Wang, H Aoki, J Yang, K Peng, R Liu, X Li, X Qiang, L Sun, EC Gurley, ...
Hepatology 65 (6), 2005-2018, 2017
Овлашћења: US National Institutes of Health, US Department of Veterans Affairs …
Conjugated bile acid–activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression
M Nagahashi, K Takabe, R Liu, K Peng, X Wang, Y Wang, NC Hait, ...
Hepatology 61 (4), 1216-1226, 2015
Овлашћења: US National Institutes of Health, US Department of Veterans Affairs …
Colonic inflammation and secondary bile acids in alcoholic cirrhosis
G Kakiyama, PB Hylemon, H Zhou, WM Pandak, DM Heuman, DJ Kang, ...
American Journal of Physiology-Gastrointestinal and Liver Physiology 306 (11 …, 2014
Овлашћења: US National Institutes of Health
Публикације и информације о финансирању аутоматски одређује рачунарски програм